Fundz

Icagen, Inc. reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEMay 25, 2017

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale May 25, 2017)

Round Type

Seed

DurhamBiotechnologyHealthcare

Quick answer

Icagen, Inc. raised $2 Million in a Seed round, dated May 25, 2017. Icagen, Inc. is based in Durham, North Carolina, United States.

How much did Icagen, Inc. raise?
Icagen, Inc. raised $2 Million in a Seed round on May 25, 2017.
What does Icagen, Inc. do?
ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.
Where is Icagen, Inc. based and how big is it?
Icagen, Inc. is based in Durham, North Carolina, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Icagen, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Kandu Health™ raised $21M on July 7, 2017.
  • Vaccinex raised $6M on July 7, 2017.
  • Venus Concept Ltd. raised $37M on July 7, 2017.
  • Outset Medical raised $4.3M (Seed) on June 30, 2017.
  • Eton Pharmaceuticals raised $20M on June 28, 2017.
  • Avitide, Inc. raised $12M on June 27, 2017.

Who to call at Icagen, Inc., and when

A new round usually means Icagen, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Icagen, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Icagen, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Icagen, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Icagen, Inc.

Location

4222 EMPEROR BLVD., SUITE 350

Durham, North Carolina, United States

About

ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Icagen, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Icagen, Inc.'s next move

See what Strategic adds

Icagen, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.